Biomarker testing played a pivotal role in shaping Samantha’s non-small cell lung cancer (NSCLC) journey. Working closely with her care team, she learned her cancer was driven by a HER2 genetic mutation—a discovery that unlocked targeted treatment options and a plan tailored specifically for her cancer. Samantha encourages everyone living with cancer to ask their care teams about biomarker testing. #ASCO #CancerCare #LifeForward | Boehringer Ingelheim

Biomarker testing is a key part of cancer care and helps to improve the cancer care path to each patient's unique needs. As more people undergo these important tests, it's crucial that they understand what the results mean for their healthcare options. Knowing your biomarker status can guide decisions and empower you to play an active role in your cancer care journey. Danielle Hicks, Chief Patient Officer at GO2 for Lung Cancer shared valuable insights that highlight the importance of raising aw